DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo


133.25 1.38 (1.04%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BAYRY $133.25 1.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $131.74
Previous Close $131.88
Daily Range $131.73 - $133.36
52-Week Range $121.20 - $146.62
Market Cap $110.2B
P/E Ratio 732.64
Dividend (Yield) $0.00 (1.6%)
Volume 134,270
Average Daily Volume 57,253
Current FY EPS $7.58





Bayer AG (ADR) (BAYRY) Description

The Company offers products, including ethical pharmaceuticals and other health care products, agricultural products and polymers. Website:

News & Commentary

3 Small-Cap Biotech Stocks to Buy if the Market Crashes

Falling markets may be creating an opportunity to pick up these three biotechnology companies at discount prices.

The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To

The over-the-counter drug market could grow to reach $70 billion in sales by 2015, but according to Brand Keys, this OTC pain reliever is lagging far behind its peers in terms of customer loyalty.

New Study Touts Benefits of Organic Goods, Questions Pesticides and GMOs

Though not earth-shattering, the largest study to date represents a continued move away from chemical use.

Regeneron's $4.7 Billion Opportunity

Regeneron recently got some good news. Check out the video below for more information.

Why Are These 3 Dow Jones Stocks Crushing the Market in 2014?

Intel, Caterpillar, and Merck were the Dow's best performers in the first half of 2014. Why did these three stocks race ahead, and where are they going next?

Why OncoMed Pharmaceuticals Inc. Shares Collapsed

OncoMed shares dive after it voluntarily halts two early-stage programs. Find out what investors should be closely monitoring going forward.

Wednesday’s Top Biotech Stories: Orexigen, Portola, and Regeneron

Orexigen, Portola, and Regeneron could all make waves across the health care sector this Wednesday morning.

Why Bayer Sold This Division to Boston Scientific

Why this acquisition made sense for both sides.

Good News at Boston Scientific: What's Next

Three recent developments help Boston Scientific, but don't fundamentally alter the thesis

Does This Study Prove Monsanto Company is Killing Our Honey Bees?

A class of insecticides has long been claimed to be at the root of the demise of honey bee populations. Do the data show that Monsanto, Bayer, and Syngenta are to blame?

See More BAYRY News...

BAYRY's Top Competitors

BAYRY $133.25 (1.04%)
Current stock: BAYRY
JNJ $100.36 (1.17%)
Current stock: JNJ
PFE $28.28 (1.25%)
Current stock: PFE
RHHBY $36.39 (1.51%)
Current stock: RHHBY